Logo image of WAI

TOP KINGWIN LTD-A (WAI) Stock Fundamental Analysis

NASDAQ:WAI - Nasdaq - KYG8923U1031 - Common Stock - Currency: USD

2.06  +0.26 (+14.44%)

After market: 1.99 -0.07 (-3.4%)

Fundamental Rating

3

WAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 230 industry peers in the Capital Markets industry. WAI has a great financial health rating, but its profitability evaluates not so good. WAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WAI has reported negative net income.
In the past year WAI has reported a negative cash flow from operations.
WAI Yearly Net Income VS EBIT VS OCF VS FCFWAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

WAI has a worse Return On Assets (-24.89%) than 89.13% of its industry peers.
Looking at the Return On Equity, with a value of -34.41%, WAI is doing worse than 85.22% of the companies in the same industry.
Industry RankSector Rank
ROA -24.89%
ROE -34.41%
ROIC N/A
ROA(3y)-0.26%
ROA(5y)N/A
ROE(3y)1.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WAI Yearly ROA, ROE, ROICWAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 -20 40 -40 60 80

1.3 Margins

The Gross Margin of WAI (65.84%) is better than 70.43% of its industry peers.
WAI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for WAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
WAI Yearly Profit, Operating, Gross MarginsWAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

WAI has more shares outstanding than it did 1 year ago.
WAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WAI Yearly Shares OutstandingWAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M 4M
WAI Yearly Total Debt VS Total AssetsWAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

WAI has an Altman-Z score of 3.33. This indicates that WAI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.33, WAI is doing good in the industry, outperforming 80.00% of the companies in the same industry.
WAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.33
ROIC/WACCN/A
WACCN/A
WAI Yearly LT Debt VS Equity VS FCFWAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 2.48 indicates that WAI has no problem at all paying its short term obligations.
WAI has a better Current ratio (2.48) than 78.70% of its industry peers.
WAI has a Quick Ratio of 2.48. This indicates that WAI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of WAI (2.48) is better than 79.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
WAI Yearly Current Assets VS Current LiabilitesWAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

WAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -185.00%.
Looking at the last year, WAI shows a very strong growth in Revenue. The Revenue has grown by 74.65%.
WAI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.90% yearly.
EPS 1Y (TTM)-185%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1277.78%
Revenue 1Y (TTM)74.65%
Revenue growth 3Y59.9%
Revenue growth 5YN/A
Sales Q2Q%724.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WAI Yearly Revenue VS EstimatesWAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WAI Price Earnings VS Forward Price EarningsWAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WAI Per share dataWAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOP KINGWIN LTD-A

NASDAQ:WAI (5/23/2025, 9:03:15 PM)

After market: 1.99 -0.07 (-3.4%)

2.06

+0.26 (+14.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.79
P/FCF N/A
P/OCF N/A
P/B 2.05
P/tB 3.47
EV/EBITDA N/A
EPS(TTM)-4.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.74
BVpS1
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.89%
ROE -34.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.84%
FCFM N/A
ROA(3y)-0.26%
ROA(5y)N/A
ROE(3y)1.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.66%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 3.33
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)205.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-185%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1277.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.65%
Revenue growth 3Y59.9%
Revenue growth 5YN/A
Sales Q2Q%724.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-169.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.95%
OCF growth 3YN/A
OCF growth 5YN/A